For respiratory disease diagnostic antibodies and antigens, Cnpair provides a comprehensive portfolio of high-quality raw materials for Influenza A/B （FluA FluB）, Respiratory Syncytial Virus (RSV), Mycoplasma pneumoniae （MP）, and 2019-nCoV detection. These IVD-grade reagents raw materials support the development of accurate, sensitive, and reliable diagnostic assays across multiple platforms, helping our partners respond effectively to global respiratory disease challenges.
Influenza A/B Virus
Influenza A and B (FluA/FluB) are highly contagious respiratory viruses that cause seasonal epidemics worldwide. Rapid and accurate detection is essential for early diagnosis, timely antiviral treatment, infection control, and public health surveillance.
- FluA NP
- FluB NP
- H1 HA
Mycoplasma Pneumoniae
Mycoplasma pneumoniae (MP) is a common cause of community-acquired respiratory tract infections, particularly in children and young adults. Accurate detection supports early diagnosis, appropriate antimicrobial therapy, and effective management of respiratory infections.
- MP
Respiratory Syncytial Virus
Respiratory Syncytial Virus (RSV) is a leading cause of acute lower respiratory tract infections, particularly in infants, older adults. Accurate detection supports early diagnosis, timely clinical intervention, infection control, and improved patient management.
- RSV
2019-nCoV Antibody/Antigen
2019-nCoV remains an important respiratory pathogen with ongoing global health impact. Accurate detection plays a critical role in infection screening, clinical diagnosis, epidemiological surveillance, and public health response.
- 2019-nCoV NP
- 2019-nCoV S
Related Posts
